Clinical Trial Update: Hybrid Closure of Congenital Heart Disease [NA]

View source ↗

Summary

A completed clinical trial from Nanjing Medical University evaluates a hybrid closure approach for pediatric ventricular septal defects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventricular Septal Defect

Snippet

Sponsor: Nanjing Medical University | Conditions: Pediatric Ventricular Septal Defects | NA | Status: COMPLETED